These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22996245)

  • 41. [Use of 18F FDG-PET in patients with suspicion of recurrent differentiated thyroid cancer by elevated antithyroglobulin antibodies levels and negative ¹³¹I scan].
    Sanz Viedma S; Borrego Dorado I; Rodríguez Rodríguez JR; Navarro González E; Vázquez Albertino R; Fernández López R; Agudo Martínez A
    Rev Esp Med Nucl; 2011; 30(2):77-82. PubMed ID: 21334773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
    Byun BH; Jeong UG; Hong SP; Min JJ; Chong A; Song HC; Bom HS
    Ann Nucl Med; 2012 Jul; 26(6):471-7. PubMed ID: 22467230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results.
    Mauri G; Cova L; Tondolo T; Ierace T; Baroli A; Di Mauro E; Pacella CM; Goldberg SN; Solbiati L
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1203-7. PubMed ID: 23666969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
    Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
    J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report.
    Ers V; Galant C; Malaise J; Rahier J; Daumerie C
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):124-7. PubMed ID: 16703258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal threshold of stimulated serum thyroglobulin level for
    Chai H; Zhang H; Yu YL; Gao YC
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):429-432. PubMed ID: 28585147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
    Schreinemakers JM; Vriens MR; Munoz-Perez N; Guerrero MA; Suh I; Rinkes IH; Gosnell J; Shen WT; Clark OH; Duh QY
    World J Surg Oncol; 2012 Sep; 10():192. PubMed ID: 22985118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of SPECT/CT for equivocal findings on (131)I whole-body scan in a patient with differentiated papillary thyroid cancer.
    Choi B; Kim DH; Son SH; Zeon S; Ahn BC
    Clin Nucl Med; 2014 Feb; 39(2):e160-2. PubMed ID: 23531738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
    Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
    Wang Y; Jiang L; Zhang X; Xu Y; Liu B
    Clin Nucl Med; 2022 Jun; 47(6):541-542. PubMed ID: 35025802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
    Lee JW; Lee SM; Lee DH; Kim YJ
    J Nucl Med; 2013 Aug; 54(8):1230-6. PubMed ID: 23813775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
    Wisotzki C; Friese M; Ehresmann J; Derlin T
    Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
    Sun YG; Feng HJ; Liu JH; Hu R; Ouyang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1571-4. PubMed ID: 21945769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
    Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
    Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axillary lymph nodes metastasis in a patient with recurrent papillary thyroid cancer: a case report.
    Hafez MT; Refky B; Elwahab KA; Arafa M; Abdou I; Elnahas W
    J Med Case Rep; 2015 Aug; 9():181. PubMed ID: 26307101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
    Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
    Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
    Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.